新冠肺炎檢測板塊走強 北京擴大核酸檢測範圍
格隆匯6月17日丨新冠肺炎檢測板塊拉昇走強,邁克生物漲9%,達安基因漲超7%,熱景生物漲超6%,安科生物、碩世生物、華大基因等紛紛跟漲。

北京市政府副祕書長陳蓓昨日在疫情防控新聞發佈會上表示,境外入京人員全部集中觀察核酸檢測,中高風險街鄉、新發地市場相關人員禁止出京。其他人員堅持非必要不出京,確需離京的,要持7日內核酸檢測陰性證明。
陳蓓表示,在十類人員核酸檢測應檢盡檢的基礎上,對過去14天內到過新發地、玉泉東、天陶紅蓮市場等重點區域人員及密接者落實檢測全覆蓋,並根據需要擴大檢測範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.